Predicted protein targets (top 18)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CYP4F2 | P78329 | 3/20 | 0.53 |
| ▸ | CYP4A11 | Q02928 | 3/20 | 0.53 |
| ▸ | CA12 | O43570 | 1/20 | 0.45 |
| ▸ | CA1 | P00915 | 1/20 | 0.45 |
| ▸ | CA2 | P00918 | 1/20 | 0.45 |
| ▸ | CA9 | Q16790 | 1/20 | 0.45 |
| ▸ | DGAT2 | Q96PD7 | 1/20 | 0.44 |
| ▸ | ALDH1A1 | P00352 | 3/20 | 0.44 |
| ▸ | GAA | P10253 | 1/20 | 0.44 |
| ▸ | CCNC | P24863 | 1/20 | 0.42 |
| ▸ | CDK8 | P49336 | 1/20 | 0.42 |
| ▸ | MAPT | P10636 | 1/20 | 0.42 |
| ▸ | TBXAS1 | P24557 | 4/20 | 0.41 |
| ▸ | NOTUM | Q6P988 | 1/20 | 0.41 |
| ▸ | LMNA | P02545 | 3/20 | 0.40 |
| ▸ | KDM4E | B2RXH2 | 2/20 | 0.40 |
| ▸ | HSD17B10 | Q99714 | 1/20 | 0.39 |
| ▸ | CYP4Z1 | Q86W10 | 1/20 | 0.39 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL30178437 | 0.88 | CYP4F2 (0.53) | CYP4F2CYP4A11CA12CA1CA2 | |
| SCHEMBL27224521 | 0.88 | CYP4F2 (0.56) | CYP4F2CYP4A11CA12CA1CA2 | |
| SCHEMBL3222285 | 0.86 | CYP4F2 (0.55) | CYP4F2CYP4A11CA12CA1CA2 | |
| SCHEMBL17540563 | 0.85 | CYP4F2 (0.50) | CYP4F2CYP4A11CA12CA1CA2 | |
| SCHEMBL31674750 | 0.85 | CYP4F2 (0.54) | CYP4F2CYP4A11CA12CA1CA2 | |
| SCHEMBL21855487 | 0.85 | CYP4F2 (0.50) | CYP4F2CYP4A11CA12CA1CA2 | |
| SCHEMBL3651691 | 0.85 | CYP4F2 (0.50) | CYP4F2CYP4A11CA12CA1CA2 | |
| SCHEMBL23579599 | 0.85 | CYP4F2 (0.50) | CYP4F2CYP4A11CA12CA1CA2 | |
| SCHEMBL8580162 | 0.84 | PKM (0.43) | TBXAS1HSD17B10 | |
| SCHEMBL3581723 | 0.81 | CYP4F2 (0.47) | CYP4F2CYP4A11CA12CA1CA2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20240217932-A1 | PYRIDIUM ESTERS | THE PROCTER AND GAMBLE COMPANY | 2024-07-04 | — | — | US | disclosed |
| EP-4374698-A1 | PYRIDINIUM ESTERS | The Procter & Gamble Company (US) | 2024-05-29 | — | — | EP | disclosed |
| WO-2021133915-A1 | ECTONUCLEOTIDE PYROPHOSPHATASE/PHOSPHODIESTERASE 1 (ENPP1) MODULATORS AND USES THEREOF | Sanford Burnham Prebys Medical Discovery Institute (US) | 2021-07-01 | — | — | WO | disclosed |
| CN-1440401-A | Amino substituted dibenzothiophene derivatives for treatmnt of disorders mediated by NP Y5 receptor | ASTRAZENECA AB (SE) | 2003-09-03 | — | — | CN | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20240217932-A1 | PYRIDIUM ESTERS | C5, CBR3, CHRM1 | CYP4F2 70/4885CYP4A11 65/4885CA12 3752/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.